C

Celldex Therapeutics
D

CLDX

27.020
USD
0.77
(2.93%)
Market Closed
Volume
36,679
EPS
-2
Div Yield
-
P/E
-10
Market Cap
1,792,621,257
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    -12.22
    (-4.13%)
    294.4 USD
    AZN
    AZN
    -1.830
    (-2.81%)
    65.635 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.16 USD
    NVS
    NVS
    -0.350
    (-0.34%)
    104.29 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.63 USD
    More
News

Title: Celldex Therapeutics

Sector: Healthcare
Industry: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.